📣 Cortechs is heading to AAIC 2025!.July 27–31 | Metro Toronto Convention Centre | Booth #1709. Join us at the Alzheimer’s Association International Conference to learn about NeuroQuant® for ARIA – Our complete solution for AI-assisted monitoring of Alzheimer’s Disease patients

🚨 When every second counts in neurocritical care, precision is everything. From traumatic brain injuries to hydrocephalus and mass effect, accurate and rapid brain imaging metrics can mean the difference between rapid intervention and devastating outcomes. 📈 In our latest

In June, we had the opportunity to engage with leading experts and passionate clinicians at two outstanding conferences — and we’re grateful to everyone who stopped by to explore how Cortechs is transforming neuroimaging and brain health!. ✅ CIRSx/SurvivingMold Annual Conference

🇺🇸 Proudly Made in the USA – Happy 4th of July from Cortechs! 🎆. As we celebrate Independence Day, we’re reminded of the power of innovation, resilience, and community that defines the American spirit. At Cortechs, we’re proud to be Made in the USA — from our advanced AI

🧠 “That kind of data is a valuable addition to our workflow.”.— Jeff Rudie, M.D., PhD, Neuroradiologist & AI Researcher. As radiologists, relying on subjective assessments of brain atrophy can lead to variability. That’s where NeuroQuant® steps in—with the ability to increase

At Cortechs, we’ve spent the first half of 2025 building on a strong foundation of growth — driving innovation, expanding globally, and deepening our partnerships. As we reflect on the year so far, it’s clear we’re moving forward with purpose and momentum. 🤝. Hear from Cortechs

We’re #LIVE at INS 2025 in Dubrovnik, Croatia! 🇭🇷. As we expand our global footprint, we’re thrilled to connect with the European neuroimaging community and highlight how NeuroQuant is reshaping clinical workflows and improving brain health outcomes across Europe and beyond. 🌍

🧠 What is Microvascular Ischemic Disease—and how can imaging teams assess it more objectively?. Microvascular ischemic disease (MVID) is increasingly recognized for its association with cognitive decline, stroke, and dementia—making it a key focus in neurological research and

📸 Event Recap: Enhanced Prostate MRI with OnQ Prostate. This week, Cortechs had the privilege of hosting an exclusive evening in Phoenix, AZ, centered around our breakthrough prostate imaging solution — OnQ Prostate. 🔬 Highlights from the evening included:.• Clinical utility

From major product milestones to global events and clinical breakthroughs, Cortechs is proud to be at the forefront of brain health and AI-powered imaging. 🧠. Want to stay in the loop? Subscribe to our monthly newsletter for exclusive product updates, expert perspectives on

🧠 As we near the end of Alzheimer’s & Brain Awareness Month, we want to take a moment to recognize the individuals, families, and clinicians working each day to navigate the challenges of Alzheimer’s disease. At Cortechs, we are deeply committed to supporting the Alzheimer’s

From breakthrough insights in neuroimaging to behind-the-scenes innovation — we’ve shared a lot, and there’s so much more coming! . 👉 Make sure you’re subscribed to our YouTube channel, so you don’t miss:.• Expert interviews.• Product deep dives.• Global event highlights.•

We’re excited to welcome Jillian Oreffice to the Cortechs team! Jillian brings extensive experience in global marketing, brand development, strategic planning, and digital engagement, driving measurable results and fostering meaningful connections worldwide. Jillian is

🧠 Seeing Alzheimer’s More Clearly with PET Imaging 🧠 . This Alzheimer’s Awareness Month, we’re highlighting the power of imaging to change the game in detecting and monitoring Alzheimer’s disease. In our latest blog, discover how PET imaging from NeuroQuant® PET enables

🚨NEW RESEARCH: A landmark, multi-center study of Restriction Spectrum Imaging (RSI) as a biomarker for prostate cancer was just published in the Journal of Urology! . 📊1,892 patients across 7 centers .🎯 Objective and reliable prediction of csPCa .📈 Significantly outperforms

🚀 Exciting Partnership News!.We're thrilled to announce our strategic distribution partnership with RMS Medical Devices to bring AI-powered imaging solutions to healthcare providers across Belgium, the Netherlands, and Luxembourg! 🇧🇪🇳🇱🇱🇺. This collaboration will expand access to

June is Men’s Health Month 👨🏥 . This month—and every month—we reaffirm our dedication to advancing the fight against prostate cancer with meaningful, innovative tools. OnQ™ Prostate is designed to support better outcomes in prostate cancer care. It empowers precise,

We are heading to the International Neuroimaging Symposium (INS), taking place from June 28–30, 2025, in beautiful Dubrovnik, Croatia! 🇭🇷 . As we continue to expand our global presence, we’re especially excited to connect with the European neuroimaging community and spotlight the

🌍 Today on World Brain Tumor Day, we recognize the global push for earlier detection, more personalized treatment, and better outcomes for patients. This day is a moment to honor the strength of patients, caregivers, and clinicians who face these diagnoses every day. 📊 A

📍 We’re #LIVE at the CIRSx/SurvivingMold Annual Conference in Tempe, AZ! . Come by our booth to see how NeuroQuant® is making a difference in the assessment of brain atrophy related to Chronic Inflammatory Response Syndrome (CIRS). Our cutting-edge imaging technology is helping